Abstract:Silk fibroin (SF) is a biomacromolecule that can be assembled into nanostructures and induce biomimetic nucleation of inorganic materials. Zeolitic imidazolate framework-8 (ZIF-8), a metal–organic framework (MOF), can be dissolved selectively under acidic pH. Here, we integrated SF and ZIF-8 to develop novel drug carriers that selectively release drug in the acidic intracellular environment of cancer cells. Specifically, SF was assembled into nanoparticles (SF-NPs), which were then loaded with an antitumor drug, doxorubicin (DOX), to form DSF-NPs. Due to the SF-mediated organization of ZIF-8 precursors such as zinc ions, the DSF-NPs further templated the nucleation of ZIF-8 onto their surface to generate core–shell-structured NPs (termed ) with ZIF-8 as a shell and DSF-NP as a core. We found that the , highly stable under neutral conditions, could be uptaken by breast cancer cells, release DOX selectively owing to dissolution of ZIF-8 shells in the acidic intracellular environment in a controlled manner, and induce cell apoptosis. We also confirmed that the could inhibit tumor growth more efficiently to reach a higher survival rate than their controls by inducing cell apoptosis in vivo. Our study suggests that SF and MOF could be combined to design a new type of cancer therapeutics.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.1c13405.Materials characterization, intracellular location, and biocompatibility; elemental line mapping of ; FTIR spectra of ZIF-8, , and SF-NPs; size distribution of DSF-NPs and ; loading capacity and EE of DOX onto SF-NPs with various concentrations; relative viability of MCF-7 cells cocultured with NPs; fluorescent images of the MCF-7 cells cocultured with FITC-labeled NPs; TEM images of (50 μg/mL) cocultured with MCF-7 cells for 12 h; H&E staining of normal organs (heart, spleen, lung, liver, and kidney) excised from the mice bearing MCF-7 tumors and treated with different NPs and their controls; polydispersity index of DSF-NPs and ; and chemical element analysis of (PDF)This article has not yet been cited by other publications.

Surface Coating of ZIF‐8 Nanoparticles with Polyacrylic Acid: A Facile Approach to Enhance Chemical Stability for Biomedical Applications

Bilayer nanocarrier with protein-acid conjugation for prolonged release and enhanced anticancer effects.

A phosphorylcholine-based zwitterionic copolymer coated ZIF-8 nanodrug with a long circulation time and charged conversion for enhanced chemotherapy.

Metal organic framework coated vesicular nano-aggregates: an intelligent 'vehicle' for sustained and leakage proof release of doxorubicin

Polydopamine-Mediated Metal-Organic Frameworks Modification for Improved Biocompatibility

Biopolymer Coating for Particle Surface Engineering and Their Biomedical Applications

pH-triggered degradation and release of doxorubicin from zeolitic imidazolate framework-8 (ZIF8) decorated with polyacrylic acid

In situ growth of ZIF-8 on cellulose microspheres with high doxorubicin loading capacity and pH-sensitive for oral drug delivery

Facile fabrications of poly (acrylic acid)-mesoporous zinc phosphate/polydopamine Janus nanoparticles as a biosafe photothermal therapy agent and a pH/NIR-responsive drug carrier

One-pot Synthesis of Poly(ethylene Glycol) Modified Zeolitic Imidazolate Framework-8 Nanoparticles: Size Control, Surface Modification and Drug Encapsulation

Biocompatible and biodegradable zeolitic imidazolate framework/polydopamine nanocarriers for dual stimulus triggered tumor thermo-chemotherapy

A novel structure of ultra-high-loading small molecules-encapsulated ZIF-8 colloid particles

Mussel-Inspired Polydopamine: A Biocompatible And Ultrastable Coating For Nanoparticles In Vivo

Biomimetic Nucleation of Metal–Organic Frameworks on Silk Fibroin Nanoparticles for Designing Core–Shell-Structured pH-Responsive Anticancer Drug Carriers

Polyacrylic Acid Nanoplatforms: Antimicrobial, Tissue Engineering, and Cancer Theranostic Applications

Folic Acid-Targeted Polydopamine-Based Surface Modification of Mesoporous Silica Nanoparticles As Delivery Vehicles for Cancer Therapy

Development of Zwitterionic Polymer-Based Doxorubicin Conjugates: Tuning the Surface Charge to Prolong the Circulation and Reduce Toxicity.

Zeolitic Imidazolate Frameworks (ZIF-8) for Biomedical Applications: A Review

Zwitterionic Strategy to Stabilize Self‐immolative Polymer Nanoarchitecture Under Physiological pH for Drug Delivery In vitro and In vivo

Microfluidic formulation of anticancer peptide loaded ZIF-8 nanoparticles for the treatment of breast cancer